An update on molecular mechanisms of curcumin effect on diabetes. Issue 10 (9th August 2022)
- Record Type:
- Journal Article
- Title:
- An update on molecular mechanisms of curcumin effect on diabetes. Issue 10 (9th August 2022)
- Main Title:
- An update on molecular mechanisms of curcumin effect on diabetes
- Authors:
- Lu, Wensong
Khatibi Shahidi, Fedora
Khorsandi, Khatereh
Hosseinzadeh, Reza
Gul, Asma
Balick, Veronica - Abstract:
- Abstract: Owing to its prevalent nature, diabetes mellitus has become one of the most serious endocrine illnesses affecting a patient's quality of life due to the manifestation of side effects such as cardiovascular diseases, retinopathy, neuropathy, and nephropathy. Curcumin ((1E, 6E) 21, 7‐bis (4‐hydroxy‐3‐methoxyphenyl)‐1, 6‐heptadiene‐3, 5‐dione), a major compound of turmeric, has been used in conventional medicine because of its safe nature and cost‐effectiveness to meliorate diabetes and its comorbidities. These effects have also been observed in rodent models of diabetes resulting in a reduction of glycemia and blood lipids. Both the preventive and therapeutic activities of this compound are due to its antioxidant and anti‐inflammatory characteristics. Furthermore, preclinical outcomes and clinical investigation demonstrate that the use of curcumin neutralizes insulin resistance, obesity, and hyperglycemia. Despite the many benefits of curcumin, its two limiting factors, solubility and bioavailability, remain a challenge for researchers; therefore, several methods such as drug formulation, nano‐drug delivery, and the use of curcumin analogs have been developed to deliver curcumin and increase its bioavailability. Practical applications: The rise of people with type 2 diabetes has become a major concern at the global healthcare level. The best diabetes treatments today are anti‐diabetic drug administration, lifestyle‐related interventions (such as healthy eating andAbstract: Owing to its prevalent nature, diabetes mellitus has become one of the most serious endocrine illnesses affecting a patient's quality of life due to the manifestation of side effects such as cardiovascular diseases, retinopathy, neuropathy, and nephropathy. Curcumin ((1E, 6E) 21, 7‐bis (4‐hydroxy‐3‐methoxyphenyl)‐1, 6‐heptadiene‐3, 5‐dione), a major compound of turmeric, has been used in conventional medicine because of its safe nature and cost‐effectiveness to meliorate diabetes and its comorbidities. These effects have also been observed in rodent models of diabetes resulting in a reduction of glycemia and blood lipids. Both the preventive and therapeutic activities of this compound are due to its antioxidant and anti‐inflammatory characteristics. Furthermore, preclinical outcomes and clinical investigation demonstrate that the use of curcumin neutralizes insulin resistance, obesity, and hyperglycemia. Despite the many benefits of curcumin, its two limiting factors, solubility and bioavailability, remain a challenge for researchers; therefore, several methods such as drug formulation, nano‐drug delivery, and the use of curcumin analogs have been developed to deliver curcumin and increase its bioavailability. Practical applications: The rise of people with type 2 diabetes has become a major concern at the global healthcare level. The best diabetes treatments today are anti‐diabetic drug administration, lifestyle‐related interventions (such as healthy eating and daily physical activity), arterial pressure detection, and fat control. The polyphenol curcumin, found in turmeric, can promote health by acting on a variety of cellular signaling pathways. This review article discusses curcumin and its role in the treatment of diabetes. Abstract : The rise of people with type 2 diabetes has become a major concern at the global healthcare level. The best diabetes treatments today are anti‐diabetic drug administration, lifestyle‐related interventions (such as healthy eating and daily physical activity), arterial pressure detection, and fat control. The polyphenol curcumin can affect diabetes and its associated complications via variety of cellular signaling pathways. This review article discusses curcumin and its role in the treatment of diabetes. … (more)
- Is Part Of:
- Journal of food biochemistry. Volume 46:Issue 10(2022)
- Journal:
- Journal of food biochemistry
- Issue:
- Volume 46:Issue 10(2022)
- Issue Display:
- Volume 46, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 46
- Issue:
- 10
- Issue Sort Value:
- 2022-0046-0010-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-08-09
- Subjects:
- antioxidant activity -- curcumin -- diabetes -- molecular mechanisms -- oxidative stress
Food -- Analysis -- Periodicals
Food -- Composition -- Periodicals
Biochemistry -- Periodicals
664.024 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1745-4514 ↗
http://www.blackwell-synergy.com/openurl?genre=journal&issn=0145-8884 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jfbc ↗ - DOI:
- 10.1111/jfbc.14358 ↗
- Languages:
- English
- ISSNs:
- 0145-8884
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4984.540000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24057.xml